Subclonal TP53 copy number is associated with prognosis in multiple myeloma - Shah, V., Johnson, D. C., Sherborne, A. L., Ellis, S., Aldridge, F. M., Howard-Reeves, J., Begum, F., Price, A., Kendall, J., Chiecchio, L., Savola, S., Jenner, M. W., Drayson, M. T., Owen, R. G., Gregory, W. M., Morgan, G. J., Davies, F. E., Houlston, R. S., Cook, G., Cairns, D. A., Jackson, G., Kaiser, M. F., on behalf of the National Cancer Research Institute Haematology Clinical Studies Group (American Society of Hematology (ASH), 2018)
6365782